Ameriprise’s iShares iBonds Mar 2018 Term Corporate ETF IBDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-17,290
Closed -$443K 3811
2017
Q2
$443K Sell
17,290
-11,190
-39% -$287K ﹤0.01% 3278
2017
Q1
$731K Sell
28,480
-1,649
-5% -$42.3K ﹤0.01% 3039
2016
Q4
$771K Buy
30,129
+10,375
+53% +$266K ﹤0.01% 3089
2016
Q3
$508K Buy
19,754
+9,198
+87% +$237K ﹤0.01% 3200
2016
Q2
$272K Buy
+10,556
New +$272K ﹤0.01% 3428
2016
Q1
Sell
-44,852
Closed -$1.15M 3940
2015
Q4
$1.15M Buy
44,852
+4,092
+10% +$105K ﹤0.01% 2888
2015
Q3
$1.05M Buy
40,760
+10,908
+37% +$280K ﹤0.01% 2956
2015
Q2
$767K Sell
29,852
-172,960
-85% -$4.46M ﹤0.01% 3249
2015
Q1
$5.25M Sell
202,812
-18,736
-8% -$483K ﹤0.01% 2084
2014
Q4
$5.66M Buy
221,548
+19,156
+9% +$492K ﹤0.01% 1972
2014
Q3
$5.2M Buy
202,392
+40,572
+25% +$1.05M ﹤0.01% 2006
2014
Q2
$4.21M Buy
161,820
+79,328
+96% +$2.05M ﹤0.01% 2178
2014
Q1
$2.12M Buy
82,492
+58,212
+240% +$1.5M ﹤0.01% 2469
2013
Q4
$613K Buy
+24,280
New +$621K ﹤0.01% 2802

Other funds holding IBDB

Ameriprise's IBDB Position: Q3 2017 in Review

Ameriprise sold out of iShares iBonds Mar 2018 Term Corporate ETF (IBDB) in Q3 2017, closing a stake of 17,290 shares — an estimated $443K sold.

Ameriprise first reported a position in IBDB in Q4 2013 and held it in 14 quarters. The position peaked at $5.66M in Q4 2014. 30 funds tracked by Wall St. Rank hold IBDB as of Q3 2017.

  • Ameriprise reported no remaining iShares iBonds Mar 2018 Term Corporate ETF position as of Q3 2017 after selling out during the quarter.
  • Ameriprise sold 17,290 iShares iBonds Mar 2018 Term Corporate ETF shares in Q3 2017, an estimated $443K.
  • Ameriprise first reported a position in iShares iBonds Mar 2018 Term Corporate ETF in Q4 2013 and held it in 14 quarters.
  • Ameriprise's iShares iBonds Mar 2018 Term Corporate ETF position peaked at $5.66M in Q4 2014.
  • 30 funds tracked by Wall St. Rank held iShares iBonds Mar 2018 Term Corporate ETF as of Q3 2017.

Based on Ameriprise's 13F filing for Q3 2017, filed 7 Nov 2017.